Take a closer look at Hugo in clinical practice.
In December 2025, the Hugo™ robotic‑assisted surgery (RAS) system received FDA U.S. clearance for use in minimally invasive urologic surgical procedures, marking a new chapter for robotic surgery in the United States.
Dr. James Porter, Chief Medical Officer for Robotic Surgical Technologies at Medtronic, shares what this moment means:
“The launch of the Hugo™ RAS system in the United States marks an important milestone and an exciting step forward for surgical innovation. As demand for minimally invasive procedures grows, robotic technology is expanding access for patients and surgeons. Robotic surgery is not a separate modality — it’s integral to modern surgical practice.
We proudly celebrate the first procedures completed in the U.S. and thank the surgeons, hospital leaders, and teams whose partnership made this progress possible. This is just the beginning.”
Hugo in Action: Join us at the AUA2026 Product Theater for a Hugo™ RAS system semi‑live surgery.
Presented by Dr. Zack McDowell and moderated by Dr. James Porter
Friday, May 15th 9:30–10:15 AM
AUA2026 Product Theater Booth #2701
And Don't Miss
How I do It: Robotic Prostatectomy Video Case Review
Presented by Dr. Ronney Abaza
Sunday, May 17th 11:30 AM –12:30 PM
Medtronic Booth #1604
Get your hands on Hugo - Visit us in the Science & Technology Hall at booth #1604
The Medtronic Hugo™ RAS system is commercially available in certain geographies. Regulatory requirements of individual countries and regions will determine approval, or market availability. Indications for use may vary.
Find indications, safety and warnings information: medtronic.com/hugo
©2026 Medtronic. Medtronic, Medtronic logo, and Engineering the extraordinary are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. 04/2026 – US-RP-2600145 – [WF#22301603]